Supernus Pharmaceuticals | Pasivo Circulante



Current Liabilities Cambio Fecha
Abbott USD 14.16B 745M 2024-12
ANI Pharmaceuticals USD 193.68M 3.75M 2024-12
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 140.77M 14.56M 2024-12
Eisai JPY 381.62B 54.78B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Indivior 939M 23M 2024-12
Novo Nordisk 208.36B 20.45B 2024-09
Pacira USD 309.92M 3.52M 2024-12
Perrigo USD 1.04B 406.3M 2024-12
Pfizer USD 43B 216M 2024-12
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
United Therapeutics USD 738.1M 135.3M 2024-12
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12



Supernus Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.